Keywords: bayer, plans, out-license, curagen, drug, candidate, german

Bayer plans to out-license CuraGen drug candidate

Article | 31 July 2006

Print This

German drug firm Bayer AG has told US drugmaker CuraGen that it plans to license BAY 76-7171 (formerly CT052), a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in